• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BTG FARNHAM LC BEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BTG FARNHAM LC BEAD Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Fatigue (1849); Foreign Body Reaction (1868)
Event Date 02/01/2016
Event Type  Injury  
Manufacturer Narrative
Event date: true event date is unknown.Event date is estimated to the first month of the clinical study (b)(6) 2016.Implant date: between (b)(6) 2016 - (b)(6) 2017.Apa citation: lakhoo, j., adams, r., dave, a., luo, l., vargo, c.J., isaacson, a.J., sher, a., fischman, a., yee, d.C., ryan, s., patel, s., duchac, d., & brown, d.B.(2020).Radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma: a retrospective, multi-center study.Cancer treatment and research communications, 25, 100208.Https://doi.Org/10.1016/j.Ctarc.2020.100208.
 
Event Description
It was reported via a retrospective, multi-center study "radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma" that patients experienced fatigue, abdominal pain and toxicity.The primary objective of this study was to evaluate overall disease and target tumor response of non-resectable hepatocellular carcinoma (hcc) after transarterial chemoembolization (tace) with a doxorubicin-loaded radiopaque microsphere.Data as abstracted from records of patients with unresectable hcc who received tace with doxorubicin loaded radiopaque lc bead lumi microspheres at one of five united states centers between february 2016 - november 2017.82 patients underwent 130 treatments.Most patients, however, received only one (45/82) or two treatments (29/82).Five patients experienced adverse events of fatigue, abdominal pain and toxicity.No grade 4-5 toxicities occurred.No treatment information was supplied in the article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LC BEAD
Manufacturer (Section D)
BTG FARNHAM
chapman house
weydon lane
farnham, surrey GU9 8 QL
UK  GU9 8QL
Manufacturer (Section G)
BTG FARNHAM
farnham, surrey GU9 8 QL
UK   GU9 8QL
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12143519
MDR Text Key260931115
Report Number2134265-2021-08694
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K083091
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/21/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-